Potent and selective hepatitis B virus reverse transcriptase inhibitor (EC50
= 3 nM); guanine analog. Inhibits hepatitis B virus replication in HepG2.2.15 cells. Displays selectively over HCMV, HSV-1, VZV, HIV and influenza (EC50
values are 15, 32, 30-60, >10 and >80 μ
M respectively). Orally bioavailable.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.
Innaimo et al.
Antimicrob. Agents Chemother., 1997;41:1444
BMS-200475, a novel carbocyclic 2'-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro
Bisacchi et al.
Bioorganic & Medicinal Chemistry Letters, 1997;7:127